January 20, 202018 November, 2020
Tumour-Treg-Targeting is a collaborative research and training project established to provide innovative and comprehensive training in antibody-based drug design to next-generation scientists in academia and industry in order to enable them to develop the next generation of antibody-based biologicals targeting and shifting the immunological environment specifically within tumours.
The project is funded by the Marie-Sklodowska-Curie Innovative Training Network within the Horizon 2020 Programme of the European Commission (2018-2022).